Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.

Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY.

J Urol. 1993 Dec;150(6):1761-4.

PMID:
8230497
2.

Citrate salts for preventing and treating calcium containing kidney stones in adults.

Phillips R, Hanchanale VS, Myatt A, Somani B, Nabi G, Biyani CS.

Cochrane Database Syst Rev. 2015 Oct 6;(10):CD010057. doi: 10.1002/14651858.CD010057.pub2. Review.

PMID:
26439475
3.

Citrate and renal calculi: an update.

Pak CY.

Miner Electrolyte Metab. 1994;20(6):371-7. Review.

PMID:
7783699
4.

Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.

Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F; CLU Working Group.

Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Review. Erratum in: Arch Ital Urol Androl. 2016 Mar;88(1):76. Ferraro, Manuel [added].

5.

Urine citrate and renal stone disease.

Goldberg H, Grass L, Vogl R, Rapoport A, Oreopoulos DG.

CMAJ. 1989 Aug 1;141(3):217-21. Review.

6.

Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.

Caudarella R, Vescini F.

Arch Ital Urol Androl. 2009 Sep;81(3):182-7. Review.

PMID:
19911682
7.

Effects of citrate on the different phases of calcium oxalate crystallization.

Tiselius HG, Berg C, Fornander AM, Nilsson MA.

Scanning Microsc. 1993 Mar;7(1):381-9; discussion 389-90. Review.

PMID:
8316807
8.

Citrate and renal calculi.

Pak CY.

Miner Electrolyte Metab. 1987;13(4):257-66. Review.

PMID:
3306318
9.

[The significance of hypocitruria in calcium oxalate induced nephrolithiasis].

Horváth C, Németh J, Büki B, Vargha P.

Orv Hetil. 1990 Nov 11;131(45):2475-8. Review. Hungarian.

PMID:
2234941
10.

Pathophysiology of hypocitraturic nephrolithiasis.

Hamm LL, Hering-Smith KS.

Endocrinol Metab Clin North Am. 2002 Dec;31(4):885-93, viii. Review.

PMID:
12474636
11.

Effects of non-pharmacological interventions on urinary citrate levels: a systematic review and meta-analysis.

Pachaly MA, Baena CP, Buiar AC, de Fraga FS, Carvalho M.

Nephrol Dial Transplant. 2016 Aug;31(8):1203-11. doi: 10.1093/ndt/gfv303. Epub 2015 Aug 26. Review.

PMID:
26311217
12.

New drug therapy for kidney stones: a review of cellulose sodium phosphate, acetohydroxamic acid, and potassium citrate.

Lake KD, Brown DC.

Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):530-9. Review.

PMID:
3896714
13.

[Citrate and renal stones].

del Valle EE, Spivacow FR, Negri AL.

Medicina (B Aires). 2013;73(4):363-8. Review. Spanish.

14.

Medical prevention of renal stone disease.

Pak CY.

Nephron. 1999;81 Suppl 1:60-5. Review.

PMID:
9873216
15.

[Use of citrate in patients with nephrolithiasis].

Marangella M.

G Ital Nefrol. 2017 Aug 1;34(4):51-60. Review. Italian.

PMID:
28762682
16.

Medical management of nephrolithiasis in Dallas: update 1987.

Pak CY.

J Urol. 1988 Sep;140(3):461-7. Review.

PMID:
3045339
17.

Preventive treatment of nephrolithiasis with alkali citrate--a critical review.

Mattle D, Hess B.

Urol Res. 2005 May;33(2):73-9. Epub 2005 May 4. Review.

PMID:
15875173
18.

[Alkaline citrates in urology. A status report].

Rinnab L, Hautmann RE, Straub M.

Urologe A. 2004 Apr;43(4):429-39. Review. German.

PMID:
15085266
19.

[Prevention of nephrolithiasis. Established strategies and new concepts].

Straub M, Hautmann RE.

Urologe A. 2004 Apr;43(4):440-9. Review. German.

PMID:
15029476

Supplemental Content

Support Center